Cargando…

High Expression of HuR in Cytoplasm, but Not Nuclei, Is Associated with Malignant Aggressiveness and Prognosis in Bladder Cancer

INTRODUCTION: Human antigen R (HuR) regulates the stability of mRNA and is associated with cell proliferation, angiogenesis, and lymphangiogenesis. However, the clinical significance and pathological role of HuR in bladder cancer remains unclear. The main objective of this investigation was to clari...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyata, Yasuyoshi, Watanabe, Shin-ichi, Sagara, Yuji, Mitsunari, Kensuke, Matsuo, Tomohiro, Ohba, Kojiro, Sakai, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596286/
https://www.ncbi.nlm.nih.gov/pubmed/23516604
http://dx.doi.org/10.1371/journal.pone.0059095
_version_ 1782262484275560448
author Miyata, Yasuyoshi
Watanabe, Shin-ichi
Sagara, Yuji
Mitsunari, Kensuke
Matsuo, Tomohiro
Ohba, Kojiro
Sakai, Hideki
author_facet Miyata, Yasuyoshi
Watanabe, Shin-ichi
Sagara, Yuji
Mitsunari, Kensuke
Matsuo, Tomohiro
Ohba, Kojiro
Sakai, Hideki
author_sort Miyata, Yasuyoshi
collection PubMed
description INTRODUCTION: Human antigen R (HuR) regulates the stability of mRNA and is associated with cell proliferation, angiogenesis, and lymphangiogenesis. However, the clinical significance and pathological role of HuR in bladder cancer remains unclear. The main objective of this investigation was to clarify the relationships between HuR expression and clinical significance and cancer cell proliferation, angiogenesis, lymphangiogenesis, and expressions of cyclooxygenase (COX)-2 and vascular endothelial growth factor (VEGF)-A, -C, and -D. METHODS: All expressions were examined by immunohistochemical techniques in 122 formalin-fixed specimens of bladder cancer patients. HuR expression was evaluated separately with cytoplasmic and nuclear staining. Cell proliferation, angiogenesis and lymphangiogenesis were measured as the percentage of Ki-67-positive cell (proliferation index, PI), CD34-stained vessels (microvessel density, MVD), and D2-40-stained vessels (lymph vessel density, LVD). Relationships between each HuR expression and clinicopathological features, prognosis, and expressions of COX-2 and VEGFs were analyzed by multi-variate analyses. HuR expression was also investigated in 10 mice of N-Butyl-N-[4-hydroxybutil] nitrosamine (BBN) induced bladder cancer model. RESULTS: In human tissues, high cytoplasmic expression was seen in 5% and 25.4% of normal and cancer cells, respectively. Nuclear HuR expression bore no significant relationship to any pathological features. However, cytoplasmic HuR expression appeared positively associated with pT stage and grade (P<0.001). In mouse tissues, similar trends were confirmed. Cytoplasmic expression correlated with PI, MVD, and LVD, as well as expression of VEGF-A and -C, but not VEGF-D. High cytoplasmic expression of HuR was a significant predictor of metastasis and cause-specific survival, and was identified as a prognostic correlative factor for metastasis (hazard ratio, 4.75; P = 0.028) in a multivariate analysis model that included pathological features. CONCLUSIONS: Cytoplasmic HuR appears to play important roles in cell proliferation, progression, and survival of bladder cancer patients. Its expression was associated with angiogenesis, lymphangiogenesis, and expressions of VEGF-A and –C.
format Online
Article
Text
id pubmed-3596286
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-35962862013-03-20 High Expression of HuR in Cytoplasm, but Not Nuclei, Is Associated with Malignant Aggressiveness and Prognosis in Bladder Cancer Miyata, Yasuyoshi Watanabe, Shin-ichi Sagara, Yuji Mitsunari, Kensuke Matsuo, Tomohiro Ohba, Kojiro Sakai, Hideki PLoS One Research Article INTRODUCTION: Human antigen R (HuR) regulates the stability of mRNA and is associated with cell proliferation, angiogenesis, and lymphangiogenesis. However, the clinical significance and pathological role of HuR in bladder cancer remains unclear. The main objective of this investigation was to clarify the relationships between HuR expression and clinical significance and cancer cell proliferation, angiogenesis, lymphangiogenesis, and expressions of cyclooxygenase (COX)-2 and vascular endothelial growth factor (VEGF)-A, -C, and -D. METHODS: All expressions were examined by immunohistochemical techniques in 122 formalin-fixed specimens of bladder cancer patients. HuR expression was evaluated separately with cytoplasmic and nuclear staining. Cell proliferation, angiogenesis and lymphangiogenesis were measured as the percentage of Ki-67-positive cell (proliferation index, PI), CD34-stained vessels (microvessel density, MVD), and D2-40-stained vessels (lymph vessel density, LVD). Relationships between each HuR expression and clinicopathological features, prognosis, and expressions of COX-2 and VEGFs were analyzed by multi-variate analyses. HuR expression was also investigated in 10 mice of N-Butyl-N-[4-hydroxybutil] nitrosamine (BBN) induced bladder cancer model. RESULTS: In human tissues, high cytoplasmic expression was seen in 5% and 25.4% of normal and cancer cells, respectively. Nuclear HuR expression bore no significant relationship to any pathological features. However, cytoplasmic HuR expression appeared positively associated with pT stage and grade (P<0.001). In mouse tissues, similar trends were confirmed. Cytoplasmic expression correlated with PI, MVD, and LVD, as well as expression of VEGF-A and -C, but not VEGF-D. High cytoplasmic expression of HuR was a significant predictor of metastasis and cause-specific survival, and was identified as a prognostic correlative factor for metastasis (hazard ratio, 4.75; P = 0.028) in a multivariate analysis model that included pathological features. CONCLUSIONS: Cytoplasmic HuR appears to play important roles in cell proliferation, progression, and survival of bladder cancer patients. Its expression was associated with angiogenesis, lymphangiogenesis, and expressions of VEGF-A and –C. Public Library of Science 2013-03-13 /pmc/articles/PMC3596286/ /pubmed/23516604 http://dx.doi.org/10.1371/journal.pone.0059095 Text en © 2013 Miyata et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Miyata, Yasuyoshi
Watanabe, Shin-ichi
Sagara, Yuji
Mitsunari, Kensuke
Matsuo, Tomohiro
Ohba, Kojiro
Sakai, Hideki
High Expression of HuR in Cytoplasm, but Not Nuclei, Is Associated with Malignant Aggressiveness and Prognosis in Bladder Cancer
title High Expression of HuR in Cytoplasm, but Not Nuclei, Is Associated with Malignant Aggressiveness and Prognosis in Bladder Cancer
title_full High Expression of HuR in Cytoplasm, but Not Nuclei, Is Associated with Malignant Aggressiveness and Prognosis in Bladder Cancer
title_fullStr High Expression of HuR in Cytoplasm, but Not Nuclei, Is Associated with Malignant Aggressiveness and Prognosis in Bladder Cancer
title_full_unstemmed High Expression of HuR in Cytoplasm, but Not Nuclei, Is Associated with Malignant Aggressiveness and Prognosis in Bladder Cancer
title_short High Expression of HuR in Cytoplasm, but Not Nuclei, Is Associated with Malignant Aggressiveness and Prognosis in Bladder Cancer
title_sort high expression of hur in cytoplasm, but not nuclei, is associated with malignant aggressiveness and prognosis in bladder cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596286/
https://www.ncbi.nlm.nih.gov/pubmed/23516604
http://dx.doi.org/10.1371/journal.pone.0059095
work_keys_str_mv AT miyatayasuyoshi highexpressionofhurincytoplasmbutnotnucleiisassociatedwithmalignantaggressivenessandprognosisinbladdercancer
AT watanabeshinichi highexpressionofhurincytoplasmbutnotnucleiisassociatedwithmalignantaggressivenessandprognosisinbladdercancer
AT sagarayuji highexpressionofhurincytoplasmbutnotnucleiisassociatedwithmalignantaggressivenessandprognosisinbladdercancer
AT mitsunarikensuke highexpressionofhurincytoplasmbutnotnucleiisassociatedwithmalignantaggressivenessandprognosisinbladdercancer
AT matsuotomohiro highexpressionofhurincytoplasmbutnotnucleiisassociatedwithmalignantaggressivenessandprognosisinbladdercancer
AT ohbakojiro highexpressionofhurincytoplasmbutnotnucleiisassociatedwithmalignantaggressivenessandprognosisinbladdercancer
AT sakaihideki highexpressionofhurincytoplasmbutnotnucleiisassociatedwithmalignantaggressivenessandprognosisinbladdercancer